Hypogonadism

Testosterone Therapy Prescribing Practices in VA Setting

Testosterone Therapy Prescribing Practices in VA Setting

By

Patients attending VA clinics may experience variability in testosterone prescribing practices for hypogonadism.

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

Long-Term Testosterone Treatment Reduced HbA1c in Men With Hypogonadism and Type 2 Diabetes

By

At 12 years of testosterone treatment, HbA1c decreased to 5.5±0.3%.

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

Adherence to Topical Testosterone Therapy in Primary and Secondary Hypogonadism

By

Low adherence to topical testosterone therapy has been linked to lowered total testosterone values and poor outcomes.

Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism

Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism

By

There has been growing concern that testosterone replacement therapy is associated with adverse cardiovascular outcomes.

Harmonized Testosterone Reference Ranges Established for Men

Harmonized Testosterone Reference Ranges Established for Men

By

Researchers have pinpointed harmonized references ranges for total testosterone levels in men.

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Implantable Testosterone Pellets Associated With Small Hematocrit Increase

Men treated with implantable testosterone pellets have a statistically significant increase in mean hematocrit, but it is unlikely to be clinically relevant.

Testosterone Solution Found Safe, Effective for Hypogonadal Men

Testosterone Solution Found Safe, Effective for Hypogonadal Men

Once-daily 2% testosterone solution (T-sol) is safe and effective for sex drive and energy in hypogonadal men.

Testosterone Undecanoate May Reduce Anemia in Men With Hypogonadism

Testosterone Undecanoate May Reduce Anemia in Men With Hypogonadism

Results showed a decreased prevalence of anemia and components of metabolic syndrome after 54 weeks of treatment.

Topical Testosterone Effectively Restores Normal Testosterone Levels in Men

Topical Testosterone Effectively Restores Normal Testosterone Levels in Men

Daily topical testosterone restored normal testosterone levels in hypogonadal men

Secondary Hypogonadism: Causes and Potential Treatment

Secondary Hypogonadism: Causes and Potential Treatment

By

Selective estrogen receptor modulators may offer a viable treatment option for men with secondary hypogonadism.

Potential Discontinuation of Testosterone Nasal Gel Supply in 2016

Potential Discontinuation of Testosterone Nasal Gel Supply in 2016

By

Acerus announced that its agreement with an affiliate of Endo International plc regarding the commercialization of Natesto (testosterone) nasal gel in the U.S. and Mexico will be terminated as of June 30, 2016.

AACE Questions Link Between Testosterone Therapy, Cardiovascular Risks

AACE Questions Link Between Testosterone Therapy, Cardiovascular Risks

By

American Association of Clinical Endocrinologists issues position statement on CV risks of testosterone therapy.

Experts: More Study of CV Safety of Testosterone Therapy Necessary

Experts: More Study of CV Safety of Testosterone Therapy Necessary

Experts suggest that more studies are necessary to evaluate testosterone therapy in men with age-related hypogonadism.

Testosterone Not Associated With Atherosclerosis in Older Men

Testosterone Not Associated With Atherosclerosis in Older Men

Researchers observed no impact on rate of change of intima-media thickness, coronary artery calcium score.

Low Testosterone May Be Risk Factor for Prostate Cancer Detection

Low Testosterone May Be Risk Factor for Prostate Cancer Detection

By

Prostate cancer is more likely to be found in men with low testosterone vs. those with normal levels.

Review: Hypogonadism Guidelines Require Updating

Review: Hypogonadism Guidelines Require Updating

By

Quality studies are still needed to answer crucial questions about TRT and prostate cancer, cardiovascular risk.

Testosterone Therapy Not Linked to Increased VTE Risk

Testosterone Therapy Not Linked to Increased VTE Risk

These findings are based on data from more than 30,000 American men aged 40 years and older.

Testosterone Therapy Failed to Improve Ejaculatory Dysfunction

Testosterone Therapy Failed to Improve Ejaculatory Dysfunction

By

Undergoing testosterone replacement therapy didn't improve ejaculatory dysfunction in men with testosterone deficiency.

More Men With Borderline Testosterone Have Depression

More Men With Borderline Testosterone Have Depression

More than half have depression or depressive symptoms, and 25% are taking antidepressants.

Testosterone Plus Fenofibrate Yields Strongest Cardiometabolic Benefit

Testosterone Plus Fenofibrate Yields Strongest Cardiometabolic Benefit

Findings in older men with high cholesterol and low testosterone.

Panel Members Question FDA Stance on Testosterone Replacement Therapy

Panel Members Question FDA Stance on Testosterone Replacement Therapy

By

The benefits of testosterone therapy outweigh the risks, according to experts, and the FDA may need to rethink its stance.

Testosterone Nasal Gel Potentially Safe, Effective in Hypogonadism

Testosterone Nasal Gel Potentially Safe, Effective in Hypogonadism

By

Three doses of testosterone nasal gel may help normalize testosterone levels in men with hypogonadism.

Letrozole Shows Promise for Treating Infertility in Obese Men

Letrozole Shows Promise for Treating Infertility in Obese Men

By

Low-dose letrozole may help treat infertility in men with obesity-related hypogonadotropic hypogonadism.

FDA: Testosterone Labels Must Include Cardiovascular, Stroke Risks

FDA: Testosterone Labels Must Include Cardiovascular, Stroke Risks

The agency now requires prescription testosterone product labels to clarify the approved use of these medications and information on potential increased risks for heart attacks and stroke.

Testosterone Therapy Doesn't Increase Prostate Cancer Risk in Hypogonadism

Testosterone Therapy Doesn't Increase Prostate Cancer Risk in Hypogonadism

Long-term testosterone therapy did not increase incidence of prostate cancer in hypogonadal men.

Testosterone Testing Increasing

Testosterone Testing Increasing

Testosterone testing appears to be increasing, especially among men with comorbidities associated with hypogonadism.

The Link Between Spinal Cord Injury and Hypogonadism in Men

The Link Between Spinal Cord Injury and Hypogonadism in Men

By

Hypogonadism is disproportionately high in men with spinal cord injury, leading researchers to suggest a connection between the two conditions.

Certain Factors Predict PSA Increases With Testosterone Gel Use

Certain Factors Predict PSA Increases With Testosterone Gel Use

Older men with lower baseline testosterone experience greater increases in prostate-specific antigen with testosterone gel use.

Low Testosterone May Raise Atherosclerosis Risk in Diabetes

Low Testosterone May Raise Atherosclerosis Risk in Diabetes

Low testosterone may increase cardiovascular risk in middle-aged men with type 2 diabetes.

Testosterone Linked to Prostate Cancer in Rats

Testosterone Linked to Prostate Cancer in Rats

By

In rats, testosterone appeared to raise the risk for prostate tumor growth.

Sign Up for Free e-Newsletters

CME Focus